Symphony Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-4,835
Closed -$411K 425
2016
Q1
$411K Buy
+4,835
New +$360K 0.04% 280
2015
Q3
Sell
-30,840
Closed -$2.78M 477
2015
Q2
$2.78M Buy
30,840
+20,042
+186% +$1.93M 0.35% 78
2015
Q1
$1.09M Buy
10,798
+2,882
+36% +$291K 0.13% 175
2014
Q4
$796K Buy
7,916
+11
+0.1% +$1.1K 0.1% 191
2014
Q3
$760K Sell
7,905
-3,459
-30% -$328K 0.08% 204
2014
Q2
$1.06M Sell
11,364
-1,312
-10% -$115K 0.11% 211
2014
Q1
$1.05M Buy
+12,676
New +$1.03M 0.1% 197

Other funds holding MJN

Symphony Asset Management's MJN Position: Q2 2016 in Review

Symphony Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2016, closing a stake of 4,835 shares — an estimated $411K sold.

Symphony Asset Management first reported a position in MJN in Q1 2014 and held it in 7 quarters. The position peaked at $2.78M in Q2 2015. 545 funds tracked by Wall St. Rank hold MJN as of Q2 2016.

  • Symphony Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2016 after selling out during the quarter.
  • Symphony Asset Management sold 4,835 Mead Johnson Nutrition Company shares in Q2 2016, an estimated $411K.
  • Symphony Asset Management first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 7 quarters.
  • Symphony Asset Management's Mead Johnson Nutrition Company position peaked at $2.78M in Q2 2015.
  • 545 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2016.

Based on Symphony Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.